Texas Children’s Global HOPE and Baylor College of Medicine Global Health, with support from the Bristol Myers Squibb Foundation ... Uganda Pediatric Association and Mulago National Referral Hospital ...

Texas Children's Hospital and Baylor College of Medicine are providing medication and other aid to fight sickle cell disease ...

Eight years later, Bristol-Myers acquired Mead Johnson & Company, which was a leader in science-based infant and children's nutrition. Squibb, on the other hand, delved into cancer research ...

The FDA has approved Bristol Myers Squibb’s (BMS) Opvido Qvantig (nivolumab and hyaluronidase ... with only 6% of cases found in children or young adults. 2 “Receiving a cancer diagnosis can be ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

If you’re under age 12, we don’t have any drug that is specifically indicated,” Dr. Lawrence F. Eichenfield said.

Several major pharmaceutical companies, including Pfizer, Bristol Myers Squibb and Sanofi, are set to raise prices on more than 250 branded medications in the U.S. starting Jan. 1, 2025 ...

The FDA approved a subcutaneous injection version of Bristol Myers Squibb nivolumab and hyaluronidase-nvhy for the treatment of several cancers including melanoma, non-small cell lung cancer and ...

Sophie Robichaud, MD, FRCP(C), Medical Microbiology and Pediatric Infectious Diseases ... Bausch & Lomb, Bristol-Myers Squibb, Eli-Lilly, Glaxo-Smith Kline, Hoechst Marion Roussel, Hoffman ...

“At Bristol Myers Squibb, we are committed to helping patients in all aspects ... that may offer patients flexibility to receive treatment outside of traditional hospital settings and reduce the ...